Table 1.
Clinical characteristics of patients at time of study and number of clonal viruses obtained
| Patient | Age/Sex | Months since diagnosis | Treatment* | Viral Load (log10) | CD4 T-cells (cells/μl) | Number of clones | Time to emergence of clones (days) |
| 1 | 35/M | 17 | none | 5.52 | 276 | 9 | 18 – 26 |
| 2 | 38/M | 26 | none | 6.67 | 7 | 9 | 11 – 20 |
| 34 | 3TC ddI LPV # | 6.32 | 18 | 16 | 11 – 20 | ||
| 3 | 41/M | 210 | none | 6.22 | 151 | 16 | 20 – 36 |
| 4 | 38/M | 114 | 3TC SQV/RTV | 5.43 | 11 | 12 | 14 – 27 |
| 5 | 40/M | 139 | 3TC ddI TDF TPV/RTV APV | 5.33 | 8 | 8 | 10 – 21 |
*Abbreviations for antiretroviral drugs are as follows: amprenavir (APV), didanosine (ddI), lamivudine (3TC), ritonavir (RTV), saquinavir (SQV), tenofovir (TDF), tipranavir (TPV). #Poor compliance suspected.